

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 4.76963885 |
| 2 | lysine catabolic process (GO:0006554) | 4.76963885 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.72979344 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.72979344 |
| 5 | glyoxylate metabolic process (GO:0046487) | 4.72346878 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.65668620 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.65668620 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.41671363 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.41671363 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 4.38036564 |
| 11 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.36365322 |
| 12 | glycine metabolic process (GO:0006544) | 4.33386362 |
| 13 | aspartate family amino acid catabolic process (GO:0009068) | 4.30596323 |
| 14 | branched-chain amino acid catabolic process (GO:0009083) | 4.29845049 |
| 15 | proline biosynthetic process (GO:0006561) | 4.24211924 |
| 16 | response to muscle activity (GO:0014850) | 4.17487284 |
| 17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.06357946 |
| 18 | serine family amino acid biosynthetic process (GO:0009070) | 4.06245295 |
| 19 | protein retention in ER lumen (GO:0006621) | 4.05057927 |
| 20 | fatty acid beta-oxidation (GO:0006635) | 4.02232762 |
| 21 | nucleoside diphosphate biosynthetic process (GO:0009133) | 4.00154853 |
| 22 | negative regulation of cell size (GO:0045792) | 3.99310241 |
| 23 | gluconeogenesis (GO:0006094) | 3.95038339 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 3.88125858 |
| 25 | serine family amino acid metabolic process (GO:0009069) | 3.85875727 |
| 26 | 2-oxoglutarate metabolic process (GO:0006103) | 3.84368304 |
| 27 | cysteine metabolic process (GO:0006534) | 3.84138488 |
| 28 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.82353222 |
| 29 | hexose biosynthetic process (GO:0019319) | 3.81310129 |
| 30 | DNA deamination (GO:0045006) | 3.80861154 |
| 31 | acetyl-CoA metabolic process (GO:0006084) | 3.77713401 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 3.75316976 |
| 33 | ATP synthesis coupled proton transport (GO:0015986) | 3.75194497 |
| 34 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.75194497 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 3.74724898 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 3.72755321 |
| 37 | monosaccharide biosynthetic process (GO:0046364) | 3.70800973 |
| 38 | AMP metabolic process (GO:0046033) | 3.69570286 |
| 39 | L-serine metabolic process (GO:0006563) | 3.69194892 |
| 40 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.68569919 |
| 41 | actin-myosin filament sliding (GO:0033275) | 3.67837927 |
| 42 | muscle filament sliding (GO:0030049) | 3.67837927 |
| 43 | oxidative phosphorylation (GO:0006119) | 3.67051123 |
| 44 | kynurenine metabolic process (GO:0070189) | 3.66116751 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 3.63647093 |
| 46 | carnitine shuttle (GO:0006853) | 3.63395031 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 3.60703118 |
| 48 | fatty acid catabolic process (GO:0009062) | 3.57527128 |
| 49 | protein complex localization (GO:0031503) | 3.56862048 |
| 50 | fatty acid oxidation (GO:0019395) | 3.55480526 |
| 51 | regulation of oxidative phosphorylation (GO:0002082) | 3.54496879 |
| 52 | sulfur amino acid catabolic process (GO:0000098) | 3.54021938 |
| 53 | regulation of translational fidelity (GO:0006450) | 3.52570766 |
| 54 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.51017746 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 3.50279988 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.47958708 |
| 57 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.47804037 |
| 58 | lipid oxidation (GO:0034440) | 3.46867873 |
| 59 | fatty acid transmembrane transport (GO:1902001) | 3.46455252 |
| 60 | protein maturation by protein folding (GO:0022417) | 3.46176719 |
| 61 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.45248274 |
| 62 | biotin metabolic process (GO:0006768) | 3.42007337 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 3.38889446 |
| 64 | folic acid metabolic process (GO:0046655) | 3.38881903 |
| 65 | muscle cell cellular homeostasis (GO:0046716) | 3.38336974 |
| 66 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.37522427 |
| 67 | respiratory electron transport chain (GO:0022904) | 3.36164109 |
| 68 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.35999965 |
| 69 | monocarboxylic acid catabolic process (GO:0072329) | 3.33926856 |
| 70 | ethanol oxidation (GO:0006069) | 3.32941530 |
| 71 | carnitine metabolic process (GO:0009437) | 3.32455682 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.32190773 |
| 73 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.29732372 |
| 74 | valine metabolic process (GO:0006573) | 3.29538769 |
| 75 | NADH metabolic process (GO:0006734) | 3.29256848 |
| 76 | glycolytic process (GO:0006096) | 3.29192835 |
| 77 | mitotic chromosome condensation (GO:0007076) | 3.29057563 |
| 78 | bile acid biosynthetic process (GO:0006699) | 3.26740066 |
| 79 | electron transport chain (GO:0022900) | 3.26458325 |
| 80 | tryptophan catabolic process (GO:0006569) | 3.25093922 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 3.25093922 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 3.25093922 |
| 83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.24579882 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.24003545 |
| 85 | organic acid catabolic process (GO:0016054) | 3.24003545 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 3.22930089 |
| 87 | aspartate family amino acid metabolic process (GO:0009066) | 3.19966501 |
| 88 | regulation of mitochondrial translation (GO:0070129) | 3.19776610 |
| 89 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.18870479 |
| 90 | regulation of cellular respiration (GO:0043457) | 3.18545697 |
| 91 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.18291488 |
| 92 | tricarboxylic acid metabolic process (GO:0072350) | 3.16424997 |
| 93 | quinone biosynthetic process (GO:1901663) | 3.12712627 |
| 94 | ubiquinone biosynthetic process (GO:0006744) | 3.12712627 |
| 95 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.10293013 |
| 96 | proline metabolic process (GO:0006560) | 3.08857314 |
| 97 | fructose metabolic process (GO:0006000) | 3.07879131 |
| 98 | oxaloacetate metabolic process (GO:0006107) | 3.05663507 |
| 99 | sarcomere organization (GO:0045214) | 3.05375608 |
| 100 | amino-acid betaine transport (GO:0015838) | 3.04828521 |
| 101 | carnitine transport (GO:0015879) | 3.04828521 |
| 102 | regulation of cofactor metabolic process (GO:0051193) | 3.04426776 |
| 103 | regulation of coenzyme metabolic process (GO:0051196) | 3.04426776 |
| 104 | creatine metabolic process (GO:0006600) | 3.04076738 |
| 105 | homocysteine metabolic process (GO:0050667) | 3.03687612 |
| 106 | negative regulation of fibrinolysis (GO:0051918) | 3.02517258 |
| 107 | carnitine transmembrane transport (GO:1902603) | 3.02178353 |
| 108 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.01307385 |
| 109 | mitochondrial fusion (GO:0008053) | 3.01251857 |
| 110 | response to mercury ion (GO:0046689) | 3.00362487 |
| 111 | cellular modified amino acid catabolic process (GO:0042219) | 2.99518158 |
| 112 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.98303012 |
| 113 | urea cycle (GO:0000050) | 2.98247913 |
| 114 | sulfur amino acid biosynthetic process (GO:0000097) | 2.98176013 |
| 115 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.97673619 |
| 116 | tryptophan metabolic process (GO:0006568) | 2.97582322 |
| 117 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.96584822 |
| 118 | aromatic amino acid family metabolic process (GO:0009072) | 2.96488468 |
| 119 | actin-mediated cell contraction (GO:0070252) | 2.96400190 |
| 120 | regulation of sequestering of triglyceride (GO:0010889) | 2.95825836 |
| 121 | regulation of fatty acid oxidation (GO:0046320) | 2.95638390 |
| 122 | glutamate metabolic process (GO:0006536) | 2.94545687 |
| 123 | ribosome assembly (GO:0042255) | 2.93994061 |
| 124 | GDP-mannose metabolic process (GO:0019673) | 2.93956781 |
| 125 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.93498868 |
| 126 | pentose-phosphate shunt (GO:0006098) | 2.93098721 |
| 127 | focal adhesion assembly (GO:0048041) | 2.92377606 |
| 128 | cell-substrate adherens junction assembly (GO:0007045) | 2.92377606 |
| 129 | urea metabolic process (GO:0019627) | 2.91842022 |
| 130 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.90521221 |
| 131 | coenzyme catabolic process (GO:0009109) | 2.90153326 |
| 132 | DNA unwinding involved in DNA replication (GO:0006268) | 2.89574846 |
| 133 | ketone body metabolic process (GO:1902224) | 2.88906459 |
| 134 | dicarboxylic acid metabolic process (GO:0043648) | 2.88275601 |
| 135 | 4-hydroxyproline metabolic process (GO:0019471) | 2.87411497 |
| 136 | imidazole-containing compound metabolic process (GO:0052803) | 2.85318378 |
| 137 | acylglycerol homeostasis (GO:0055090) | 2.84921855 |
| 138 | triglyceride homeostasis (GO:0070328) | 2.84921855 |
| 139 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.83911187 |
| 140 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.82854524 |
| 141 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.79311830 |
| 142 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.79180181 |
| 143 | histone arginine methylation (GO:0034969) | 2.78796176 |
| 144 | regulation of fibrinolysis (GO:0051917) | 2.76998068 |
| 145 | myofibril assembly (GO:0030239) | 2.76126297 |
| 146 | adherens junction assembly (GO:0034333) | 2.74857033 |
| 147 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.74809122 |
| 148 | one-carbon metabolic process (GO:0006730) | 2.74757973 |
| 149 | small molecule catabolic process (GO:0044282) | 2.73980003 |
| 150 | succinate metabolic process (GO:0006105) | 2.73565805 |
| 151 | ubiquinone metabolic process (GO:0006743) | 2.72555337 |
| 152 | barbed-end actin filament capping (GO:0051016) | 2.72324477 |
| 153 | response to nitrosative stress (GO:0051409) | 2.72061995 |
| 154 | L-methionine salvage (GO:0071267) | 2.70653846 |
| 155 | L-methionine biosynthetic process (GO:0071265) | 2.70653846 |
| 156 | amino acid salvage (GO:0043102) | 2.70653846 |
| 157 | ribosomal small subunit biogenesis (GO:0042274) | 2.69195247 |
| 158 | ADP metabolic process (GO:0046031) | 2.68639778 |
| 159 | nitrogen cycle metabolic process (GO:0071941) | 2.68381980 |
| 160 | cellular protein complex localization (GO:0034629) | 2.67721307 |
| 161 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.67374803 |
| 162 | formation of translation preinitiation complex (GO:0001731) | 2.67182388 |
| 163 | peptidyl-arginine methylation (GO:0018216) | 2.66336859 |
| 164 | peptidyl-arginine N-methylation (GO:0035246) | 2.66336859 |
| 165 | regulation of protein sumoylation (GO:0033233) | 2.64597040 |
| 166 | DNA strand elongation (GO:0022616) | 2.63772065 |
| 167 | NADPH regeneration (GO:0006740) | 2.61872254 |
| 168 | pyruvate metabolic process (GO:0006090) | 2.60542338 |
| 169 | glycogen metabolic process (GO:0005977) | 2.55253404 |
| 170 | glucose catabolic process (GO:0006007) | 2.54976663 |
| 171 | apoptotic process involved in morphogenesis (GO:0060561) | 2.54397168 |
| 172 | IMP metabolic process (GO:0046040) | 2.52833185 |
| 173 | negative regulation of necroptotic process (GO:0060546) | 2.50772393 |
| 174 | positive regulation of catecholamine secretion (GO:0033605) | 2.50220554 |
| 175 | heterochromatin organization (GO:0070828) | 2.49402073 |
| 176 | rRNA transcription (GO:0009303) | 2.49051511 |
| 177 | maternal placenta development (GO:0001893) | 2.48551014 |
| 178 | glucan metabolic process (GO:0044042) | 2.48041429 |
| 179 | cellular glucan metabolic process (GO:0006073) | 2.48041429 |
| 180 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.45128166 |
| 181 | regulation of autophagic vacuole assembly (GO:2000785) | 2.44888232 |
| 182 | nuclear envelope reassembly (GO:0031468) | 2.42862471 |
| 183 | mitotic nuclear envelope reassembly (GO:0007084) | 2.42862471 |
| 184 | negative regulation of microtubule polymerization (GO:0031115) | 2.41537918 |
| 185 | regulation of translational termination (GO:0006449) | 2.41491762 |
| 186 | glutamine family amino acid catabolic process (GO:0009065) | 2.38990290 |
| 187 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.38387081 |
| 188 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.37835928 |
| 189 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.37835928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.82477707 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.47800367 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.60833221 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60535467 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.53693218 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.26088824 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65474755 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.60742643 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.59428753 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.57702268 |
| 11 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.53398490 |
| 12 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.50425131 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.49611322 |
| 14 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.45132794 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37080177 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32123434 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.24852879 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.22566990 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.22416914 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18532482 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17942647 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.09368141 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08995908 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08759271 |
| 25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02047681 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.98991928 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95593463 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94035674 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.90639895 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.87771440 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87625562 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87089257 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.86507486 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85959526 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84224427 |
| 36 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81000800 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75599221 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.66313846 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.65638018 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65161534 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.64249297 |
| 42 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.61438354 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61325942 |
| 44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60613048 |
| 45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.59545725 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58958817 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.57694541 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57253327 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55262576 |
| 50 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.54156916 |
| 51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50566956 |
| 52 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50441414 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49629271 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49345360 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.47803110 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47705669 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46828864 |
| 58 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46120282 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45656707 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.45275989 |
| 61 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43675581 |
| 62 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.40772056 |
| 63 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39863367 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39564639 |
| 65 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33146683 |
| 66 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.31797254 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.30370960 |
| 68 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29448734 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28503958 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27913794 |
| 71 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26589278 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25729883 |
| 73 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.25636485 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25480930 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24347236 |
| 76 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.23048390 |
| 77 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.22992674 |
| 78 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.22882471 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21865382 |
| 80 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21492975 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20349275 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19277977 |
| 83 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.19268950 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18522677 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18281091 |
| 86 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17908550 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16770827 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16422507 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14749075 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14416837 |
| 91 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13885650 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13743770 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13002697 |
| 94 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11398063 |
| 95 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10716398 |
| 96 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09687004 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09331840 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09204362 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08416076 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08223994 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07095258 |
| 102 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06421086 |
| 103 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06392437 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05941706 |
| 105 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05775475 |
| 106 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05614172 |
| 107 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04917046 |
| 108 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.04274554 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04248618 |
| 110 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03411425 |
| 111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03193798 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02702779 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01397878 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01210759 |
| 115 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.00262802 |
| 116 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99399658 |
| 117 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99230531 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99170505 |
| 119 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.99146357 |
| 120 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98656721 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 0.98383860 |
| 122 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98240062 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97960320 |
| 124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97952515 |
| 125 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97429414 |
| 126 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96182571 |
| 127 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95237496 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93206991 |
| 129 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92385105 |
| 130 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92148456 |
| 131 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91107328 |
| 132 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90744874 |
| 133 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89470132 |
| 134 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88797114 |
| 135 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88308285 |
| 136 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88189378 |
| 137 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85492193 |
| 138 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85470961 |
| 139 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.84656474 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84581704 |
| 141 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.84537065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.02653596 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.89828542 |
| 3 | MP0005360_urolithiasis | 4.29326068 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.70462631 |
| 5 | MP0005365_abnormal_bile_salt | 3.62331948 |
| 6 | MP0003646_muscle_fatigue | 3.37215453 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.30460672 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.85619672 |
| 9 | MP0005670_abnormal_white_adipose | 2.69237417 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68287645 |
| 11 | MP0005332_abnormal_amino_acid | 2.63610804 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.41781987 |
| 13 | MP0009840_abnormal_foam_cell | 2.41106908 |
| 14 | MP0003195_calcinosis | 2.37173864 |
| 15 | MP0000751_myopathy | 2.31770325 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.30398956 |
| 17 | MP0003315_abnormal_perineum_morphology | 2.22699356 |
| 18 | MP0005330_cardiomyopathy | 2.18445733 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.15322822 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.07365033 |
| 21 | MP0004084_abnormal_cardiac_muscle | 2.03577815 |
| 22 | MP0005083_abnormal_biliary_tract | 2.00103647 |
| 23 | MP0001849_ear_inflammation | 1.98005934 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.92241347 |
| 25 | MP0005666_abnormal_adipose_tissue | 1.91178738 |
| 26 | MP0003186_abnormal_redox_activity | 1.90244635 |
| 27 | MP0003252_abnormal_bile_duct | 1.88237417 |
| 28 | MP0000537_abnormal_urethra_morphology | 1.87412136 |
| 29 | MP0002269_muscular_atrophy | 1.86738031 |
| 30 | MP0004858_abnormal_nervous_system | 1.82255842 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.78275504 |
| 32 | MP0000749_muscle_degeneration | 1.78261151 |
| 33 | MP0000733_abnormal_muscle_development | 1.71875351 |
| 34 | MP0004130_abnormal_muscle_cell | 1.67943407 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.66365222 |
| 36 | MP0004233_abnormal_muscle_weight | 1.64048283 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.62309380 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.60554285 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.53705982 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.50806853 |
| 41 | MP0002118_abnormal_lipid_homeostasis | 1.49414732 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.44199790 |
| 43 | MP0004087_abnormal_muscle_fiber | 1.40110389 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.35474553 |
| 45 | MP0002796_impaired_skin_barrier | 1.34155228 |
| 46 | MP0008260_abnormal_autophagy | 1.33378769 |
| 47 | MP0000747_muscle_weakness | 1.32823486 |
| 48 | MP0005266_abnormal_metabolism | 1.30868364 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.29802722 |
| 50 | MP0004272_abnormal_basement_membrane | 1.28803981 |
| 51 | MP0003011_delayed_dark_adaptation | 1.28605713 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.27316625 |
| 53 | MP0001764_abnormal_homeostasis | 1.26317242 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.26183132 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24383316 |
| 56 | MP0001730_embryonic_growth_arrest | 1.23749067 |
| 57 | MP0005501_abnormal_skin_physiology | 1.23726491 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.21980985 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21892934 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.21348062 |
| 61 | MP0009697_abnormal_copulation | 1.20143741 |
| 62 | MP0003077_abnormal_cell_cycle | 1.19870967 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.19461483 |
| 64 | MP0002249_abnormal_larynx_morphology | 1.17887579 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.17640625 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.16635252 |
| 67 | MP0005375_adipose_tissue_phenotype | 1.15919113 |
| 68 | MP0000609_abnormal_liver_physiology | 1.15513360 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.11704181 |
| 70 | MP0003718_maternal_effect | 1.10833385 |
| 71 | MP0000759_abnormal_skeletal_muscle | 1.09505383 |
| 72 | MP0005410_abnormal_fertilization | 1.07938440 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.07533899 |
| 74 | MP0005623_abnormal_meninges_morphology | 1.07419039 |
| 75 | MP0004133_heterotaxia | 1.06863750 |
| 76 | MP0002972_abnormal_cardiac_muscle | 1.06720366 |
| 77 | MP0004043_abnormal_pH_regulation | 1.06007347 |
| 78 | MP0002106_abnormal_muscle_physiology | 1.04648149 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.02430877 |
| 80 | MP0001661_extended_life_span | 1.01352662 |
| 81 | MP0001544_abnormal_cardiovascular_syste | 1.00889059 |
| 82 | MP0005385_cardiovascular_system_phenoty | 1.00889059 |
| 83 | MP0001346_abnormal_lacrimal_gland | 0.99981164 |
| 84 | MP0010630_abnormal_cardiac_muscle | 0.94864912 |
| 85 | MP0002080_prenatal_lethality | 0.94670045 |
| 86 | MP0002160_abnormal_reproductive_system | 0.93815150 |
| 87 | MP0005369_muscle_phenotype | 0.91937661 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.91340739 |
| 89 | MP0008004_abnormal_stomach_pH | 0.91087767 |
| 90 | MP0002132_abnormal_respiratory_system | 0.90625799 |
| 91 | MP0000350_abnormal_cell_proliferation | 0.90575878 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.88994578 |
| 93 | MP0002971_abnormal_brown_adipose | 0.88377143 |
| 94 | MP0006138_congestive_heart_failure | 0.88187440 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.85629963 |
| 96 | MP0003385_abnormal_body_wall | 0.84619327 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.84450162 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.82816141 |
| 99 | MP0003868_abnormal_feces_composition | 0.81035719 |
| 100 | MP0003111_abnormal_nucleus_morphology | 0.79855624 |
| 101 | MP0008932_abnormal_embryonic_tissue | 0.79575984 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.79470784 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.79274643 |
| 104 | MP0005647_abnormal_sex_gland | 0.77622787 |
| 105 | MP0000358_abnormal_cell_content/ | 0.76054040 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.75283445 |
| 107 | MP0005380_embryogenesis_phenotype | 0.74325540 |
| 108 | MP0001672_abnormal_embryogenesis/_devel | 0.74325540 |
| 109 | MP0004510_myositis | 0.73758836 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.73118161 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.72516440 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.72434750 |
| 113 | MP0003329_amyloid_beta_deposits | 0.72359859 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.72159374 |
| 115 | MP0003984_embryonic_growth_retardation | 0.71898502 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.71182736 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.70304634 |
| 118 | MP0004085_abnormal_heartbeat | 0.68685586 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.66858429 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.66789807 |
| 121 | MP0004957_abnormal_blastocyst_morpholog | 0.66519475 |
| 122 | MP0005451_abnormal_body_composition | 0.66241146 |
| 123 | MP0000566_synostosis | 0.65670368 |
| 124 | MP0002088_abnormal_embryonic_growth/wei | 0.65529926 |
| 125 | MP0005621_abnormal_cell_physiology | 0.64674439 |
| 126 | MP0000598_abnormal_liver_morphology | 0.64598125 |
| 127 | MP0008438_abnormal_cutaneous_collagen | 0.64576527 |
| 128 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64128611 |
| 129 | MP0005334_abnormal_fat_pad | 0.63933136 |
| 130 | MP0002970_abnormal_white_adipose | 0.63175992 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.63115200 |
| 132 | MP0001881_abnormal_mammary_gland | 0.61580929 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.61422126 |
| 134 | MP0005535_abnormal_body_temperature | 0.59904681 |
| 135 | MP0010030_abnormal_orbit_morphology | 0.59223653 |
| 136 | MP0009672_abnormal_birth_weight | 0.58737373 |
| 137 | MP0002108_abnormal_muscle_morphology | 0.58731693 |
| 138 | MP0002210_abnormal_sex_determination | 0.57686055 |
| 139 | MP0001145_abnormal_male_reproductive | 0.57600112 |
| 140 | MP0009379_abnormal_foot_pigmentation | 0.55367783 |
| 141 | MP0003878_abnormal_ear_physiology | 0.54810903 |
| 142 | MP0005377_hearing/vestibular/ear_phenot | 0.54810903 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.54053133 |
| 144 | MP0001929_abnormal_gametogenesis | 0.53995074 |
| 145 | MP0003693_abnormal_embryo_hatching | 0.53860544 |
| 146 | MP0005395_other_phenotype | 0.53426239 |
| 147 | MP0003698_abnormal_male_reproductive | 0.53114343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.95384885 |
| 2 | Hyperglycinuria (HP:0003108) | 4.49189632 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.40485178 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.39420859 |
| 5 | Myopathic facies (HP:0002058) | 4.16537286 |
| 6 | Hyperammonemia (HP:0001987) | 4.16426807 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.14956574 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 4.14956574 |
| 9 | Hepatic necrosis (HP:0002605) | 4.14155192 |
| 10 | Ketosis (HP:0001946) | 4.09579937 |
| 11 | Myoglobinuria (HP:0002913) | 3.96972876 |
| 12 | Hyperglycinemia (HP:0002154) | 3.90637264 |
| 13 | Cerebral edema (HP:0002181) | 3.80419900 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.80372944 |
| 15 | Dicarboxylic aciduria (HP:0003215) | 3.77161826 |
| 16 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.77161826 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.74372512 |
| 18 | Nemaline bodies (HP:0003798) | 3.74000049 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.71810381 |
| 20 | Ketoacidosis (HP:0001993) | 3.71403687 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 3.70976228 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.65595221 |
| 23 | Spinal rigidity (HP:0003306) | 3.64437342 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.59588611 |
| 25 | Acute encephalopathy (HP:0006846) | 3.52669638 |
| 26 | Scapular winging (HP:0003691) | 3.49054817 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.47986590 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 3.43792601 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.39239479 |
| 30 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.36644149 |
| 31 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.36644149 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.36385222 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.31317185 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.30220516 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.29414457 |
| 36 | Increased muscle lipid content (HP:0009058) | 3.29318693 |
| 37 | Lethargy (HP:0001254) | 3.28384376 |
| 38 | Lactic acidosis (HP:0003128) | 3.26833586 |
| 39 | Acute necrotizing encephalopathy (HP:0006965) | 3.26393407 |
| 40 | Xanthomatosis (HP:0000991) | 3.24901207 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 3.24200737 |
| 42 | Achilles tendon contracture (HP:0001771) | 3.22555577 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 3.11678324 |
| 44 | Deep venous thrombosis (HP:0002625) | 3.10281342 |
| 45 | Rimmed vacuoles (HP:0003805) | 3.08497209 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 3.06235694 |
| 47 | Neck muscle weakness (HP:0000467) | 3.05892574 |
| 48 | Progressive external ophthalmoplegia (HP:0000590) | 3.05811664 |
| 49 | Increased CSF lactate (HP:0002490) | 3.03801409 |
| 50 | Increased connective tissue (HP:0009025) | 3.03540365 |
| 51 | Mitochondrial inheritance (HP:0001427) | 3.03421891 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 3.02483623 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.00579719 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.99509325 |
| 55 | Increased serum lactate (HP:0002151) | 2.95167957 |
| 56 | Distal lower limb muscle weakness (HP:0009053) | 2.94808111 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.89260777 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.89260777 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.87515651 |
| 60 | Increased intramyocellular lipid droplets (HP:0012240) | 2.86675602 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 2.84705284 |
| 62 | Ragged-red muscle fibers (HP:0003200) | 2.82134974 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.81816838 |
| 64 | Hyperlipoproteinemia (HP:0010980) | 2.81345811 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.80608100 |
| 66 | Proximal tubulopathy (HP:0000114) | 2.78925448 |
| 67 | Back pain (HP:0003418) | 2.78731748 |
| 68 | Progressive muscle weakness (HP:0003323) | 2.77868762 |
| 69 | Abnormality of alanine metabolism (HP:0010916) | 2.75884977 |
| 70 | Hyperalaninemia (HP:0003348) | 2.75884977 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.75884977 |
| 72 | Resting tremor (HP:0002322) | 2.74906692 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.72038201 |
| 74 | Sudden death (HP:0001699) | 2.70596213 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.70513598 |
| 76 | Bulbar palsy (HP:0001283) | 2.65852873 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.65478415 |
| 78 | Metabolic acidosis (HP:0001942) | 2.61875716 |
| 79 | Exercise-induced myalgia (HP:0003738) | 2.61599869 |
| 80 | Limb-girdle muscle atrophy (HP:0003797) | 2.61366783 |
| 81 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.60864292 |
| 82 | Exercise intolerance (HP:0003546) | 2.57657174 |
| 83 | Foot dorsiflexor weakness (HP:0009027) | 2.56932191 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56688444 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.55278572 |
| 86 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.54744523 |
| 87 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53190332 |
| 88 | Hyperacusis (HP:0010780) | 2.53047024 |
| 89 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.50277096 |
| 90 | Difficulty climbing stairs (HP:0003551) | 2.48903432 |
| 91 | Exercise-induced muscle cramps (HP:0003710) | 2.48194277 |
| 92 | Gout (HP:0001997) | 2.48084666 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.47860496 |
| 94 | Respiratory failure (HP:0002878) | 2.47321807 |
| 95 | CNS demyelination (HP:0007305) | 2.45138213 |
| 96 | Palpitations (HP:0001962) | 2.43292109 |
| 97 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.42888920 |
| 98 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42628330 |
| 99 | Vertebral compression fractures (HP:0002953) | 2.42479732 |
| 100 | Prolonged partial thromboplastin time (HP:0003645) | 2.41785574 |
| 101 | Ventricular tachycardia (HP:0004756) | 2.39922710 |
| 102 | Vomiting (HP:0002013) | 2.38767987 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 2.36587409 |
| 104 | Generalized amyotrophy (HP:0003700) | 2.34718603 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.30179235 |
| 106 | Methylmalonic aciduria (HP:0012120) | 2.27863923 |
| 107 | Muscle fiber splitting (HP:0003555) | 2.20169141 |
| 108 | Multiple enchondromatosis (HP:0005701) | 2.17137952 |
| 109 | Premature rupture of membranes (HP:0001788) | 2.12088779 |
| 110 | Thoracic kyphosis (HP:0002942) | 2.09505838 |
| 111 | Diaphragmatic weakness (HP:0009113) | 2.09053399 |
| 112 | Distal arthrogryposis (HP:0005684) | 2.08402291 |
| 113 | Lipoatrophy (HP:0100578) | 2.08138905 |
| 114 | Nausea (HP:0002018) | 2.08116020 |
| 115 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06604196 |
| 116 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06181780 |
| 117 | Abnormality of the intrinsic pathway (HP:0010989) | 2.05872799 |
| 118 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04355618 |
| 119 | Testicular atrophy (HP:0000029) | 2.04217565 |
| 120 | Muscle stiffness (HP:0003552) | 2.03379232 |
| 121 | Increased hepatocellular lipid droplets (HP:0006565) | 2.02921929 |
| 122 | Late onset (HP:0003584) | 2.02604429 |
| 123 | Self-mutilation (HP:0000742) | 2.01824040 |
| 124 | Trismus (HP:0000211) | 2.00583990 |
| 125 | Reticulocytopenia (HP:0001896) | 2.00102673 |
| 126 | Microvesicular hepatic steatosis (HP:0001414) | 1.99483388 |
| 127 | Increased purine levels (HP:0004368) | 1.99159516 |
| 128 | Hyperuricemia (HP:0002149) | 1.99159516 |
| 129 | Dilated cardiomyopathy (HP:0001644) | 1.97320467 |
| 130 | Elbow flexion contracture (HP:0002987) | 1.95379993 |
| 131 | Protrusio acetabuli (HP:0003179) | 1.93257132 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.92632967 |
| 133 | Reticulocytosis (HP:0001923) | 1.90970446 |
| 134 | Epidermoid cyst (HP:0200040) | 1.90250014 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 1.89407107 |
| 136 | Cholecystitis (HP:0001082) | 1.89407107 |
| 137 | Shoulder girdle muscle weakness (HP:0003547) | 1.88674567 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.86939063 |
| 139 | Abnormality of the thoracic spine (HP:0100711) | 1.86899985 |
| 140 | Complement deficiency (HP:0004431) | 1.84443114 |
| 141 | Emotional lability (HP:0000712) | 1.83724167 |
| 142 | Cholelithiasis (HP:0001081) | 1.83546466 |
| 143 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83328853 |
| 144 | Calf muscle hypertrophy (HP:0008981) | 1.83123170 |
| 145 | Glycosuria (HP:0003076) | 1.82660795 |
| 146 | Abnormality of urine glucose concentration (HP:0011016) | 1.82660795 |
| 147 | Neoplasm of the adrenal gland (HP:0100631) | 1.82074288 |
| 148 | Opisthotonus (HP:0002179) | 1.81954081 |
| 149 | Leukodystrophy (HP:0002415) | 1.81646576 |
| 150 | Lower limb amyotrophy (HP:0007210) | 1.80958630 |
| 151 | Asymmetric septal hypertrophy (HP:0001670) | 1.80026486 |
| 152 | Round ear (HP:0100830) | 1.79671840 |
| 153 | Ulnar bowing (HP:0003031) | 1.79304818 |
| 154 | Axonal loss (HP:0003447) | 1.77336073 |
| 155 | Breech presentation (HP:0001623) | 1.70746220 |
| 156 | Insomnia (HP:0100785) | 1.70480602 |
| 157 | Calcaneovalgus deformity (HP:0001848) | 1.70303346 |
| 158 | Abnormality of the umbilical cord (HP:0010881) | 1.67429790 |
| 159 | Pelvic girdle muscle weakness (HP:0003749) | 1.67424234 |
| 160 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.67285039 |
| 161 | Frequent falls (HP:0002359) | 1.66469687 |
| 162 | Distal upper limb amyotrophy (HP:0007149) | 1.66368440 |
| 163 | Upper limb amyotrophy (HP:0009129) | 1.66368440 |
| 164 | Easy fatigability (HP:0003388) | 1.65779045 |
| 165 | Malignant hyperthermia (HP:0002047) | 1.65085128 |
| 166 | Abnormality of the tricuspid valve (HP:0001702) | 1.62721145 |
| 167 | Abnormality of the gallbladder (HP:0005264) | 1.62611582 |
| 168 | Abnormality of the columella (HP:0009929) | 1.58043486 |
| 169 | Sparse lateral eyebrow (HP:0005338) | 1.57606791 |
| 170 | Muscular dystrophy (HP:0003560) | 1.57446007 |
| 171 | Generalized muscle weakness (HP:0003324) | 1.57295353 |
| 172 | Proximal amyotrophy (HP:0007126) | 1.55058352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.95280133 |
| 2 | BUB1 | 3.44602191 |
| 3 | PDK4 | 3.33472163 |
| 4 | PDK3 | 3.33472163 |
| 5 | SMG1 | 2.87483870 |
| 6 | STK16 | 2.87075064 |
| 7 | EEF2K | 2.49403306 |
| 8 | NEK1 | 2.46039181 |
| 9 | IRAK3 | 2.38247784 |
| 10 | ARAF | 2.36685248 |
| 11 | ZAK | 2.34641724 |
| 12 | PINK1 | 2.31851111 |
| 13 | LMTK2 | 2.22614418 |
| 14 | PRPF4B | 1.97089327 |
| 15 | TLK1 | 1.97042320 |
| 16 | PKN2 | 1.90931544 |
| 17 | PHKG2 | 1.86490819 |
| 18 | PHKG1 | 1.86490819 |
| 19 | PDK2 | 1.86408362 |
| 20 | WEE1 | 1.85861310 |
| 21 | VRK2 | 1.81369291 |
| 22 | ERN1 | 1.78851112 |
| 23 | TRIB3 | 1.74511970 |
| 24 | NME2 | 1.71915319 |
| 25 | MARK1 | 1.71523953 |
| 26 | LATS2 | 1.70118084 |
| 27 | CDK12 | 1.68459044 |
| 28 | TTN | 1.68451615 |
| 29 | OBSCN | 1.59932599 |
| 30 | IRAK2 | 1.52201799 |
| 31 | PLK4 | 1.50524789 |
| 32 | TTK | 1.49336339 |
| 33 | MARK3 | 1.44632708 |
| 34 | EPHA2 | 1.44592910 |
| 35 | STK38L | 1.43166053 |
| 36 | MST1R | 1.41089440 |
| 37 | EIF2AK1 | 1.35595096 |
| 38 | TESK2 | 1.34092755 |
| 39 | MAP3K11 | 1.29431905 |
| 40 | PBK | 1.27421764 |
| 41 | PNCK | 1.27382320 |
| 42 | NME1 | 1.23401343 |
| 43 | DYRK3 | 1.21387503 |
| 44 | WNK4 | 1.19730820 |
| 45 | TESK1 | 1.19098992 |
| 46 | KDR | 1.16557992 |
| 47 | EPHA4 | 1.14631815 |
| 48 | MAP3K1 | 1.13902860 |
| 49 | SIK1 | 1.12472354 |
| 50 | MYLK | 1.09957812 |
| 51 | MAPKAPK3 | 1.02931504 |
| 52 | KSR2 | 1.01523581 |
| 53 | AURKA | 1.01217176 |
| 54 | RPS6KB2 | 0.99541975 |
| 55 | ICK | 0.96771605 |
| 56 | ABL2 | 0.96537216 |
| 57 | CDK8 | 0.94380472 |
| 58 | CCNB1 | 0.94075133 |
| 59 | RIPK1 | 0.92510947 |
| 60 | MAP3K10 | 0.91064271 |
| 61 | CSNK1A1L | 0.90777038 |
| 62 | IRAK1 | 0.89924025 |
| 63 | CSNK1G3 | 0.88791180 |
| 64 | SRPK1 | 0.87087853 |
| 65 | MAP2K3 | 0.85845905 |
| 66 | DAPK3 | 0.85711019 |
| 67 | MOS | 0.85521564 |
| 68 | BRAF | 0.84087247 |
| 69 | MAP3K13 | 0.83351212 |
| 70 | LATS1 | 0.78255235 |
| 71 | CAMK2G | 0.76507403 |
| 72 | FLT3 | 0.75906989 |
| 73 | MAP3K9 | 0.75285470 |
| 74 | CAMK2D | 0.75059108 |
| 75 | MUSK | 0.74828490 |
| 76 | CDC7 | 0.73290754 |
| 77 | NEK2 | 0.71882767 |
| 78 | CDK14 | 0.69790460 |
| 79 | MAP2K4 | 0.69292103 |
| 80 | EIF2AK3 | 0.67849280 |
| 81 | VRK1 | 0.67760442 |
| 82 | PRKD3 | 0.66964667 |
| 83 | PLK1 | 0.65854077 |
| 84 | RAF1 | 0.65435797 |
| 85 | SCYL2 | 0.64953003 |
| 86 | PDGFRA | 0.64799508 |
| 87 | LIMK1 | 0.64646993 |
| 88 | STK39 | 0.63637967 |
| 89 | EPHB1 | 0.62688857 |
| 90 | MAPK12 | 0.62399358 |
| 91 | PDPK1 | 0.61753859 |
| 92 | CDK7 | 0.61743084 |
| 93 | MAP2K7 | 0.58523971 |
| 94 | INSRR | 0.58512819 |
| 95 | TIE1 | 0.58033686 |
| 96 | FGFR4 | 0.55578649 |
| 97 | AKT2 | 0.55305294 |
| 98 | STK38 | 0.54685900 |
| 99 | TAOK2 | 0.54658958 |
| 100 | LRRK2 | 0.53955564 |
| 101 | DYRK2 | 0.53118962 |
| 102 | PTK2 | 0.52716509 |
| 103 | PRKCI | 0.52197414 |
| 104 | CHEK2 | 0.50418132 |
| 105 | MAP3K8 | 0.50275470 |
| 106 | MET | 0.49885984 |
| 107 | PRKG2 | 0.49662302 |
| 108 | DAPK1 | 0.49342211 |
| 109 | PAK6 | 0.49241460 |
| 110 | MAP3K5 | 0.48227485 |
| 111 | MAP3K3 | 0.47359506 |
| 112 | BRSK1 | 0.46514761 |
| 113 | PAK3 | 0.45581533 |
| 114 | CDK15 | 0.44225794 |
| 115 | PAK4 | 0.43818390 |
| 116 | CDK11A | 0.43726356 |
| 117 | CDK9 | 0.41669975 |
| 118 | CSNK1G1 | 0.41669655 |
| 119 | AURKB | 0.41233284 |
| 120 | ILK | 0.41086189 |
| 121 | CSNK1E | 0.40451677 |
| 122 | RPS6KB1 | 0.40041776 |
| 123 | PAK1 | 0.39999264 |
| 124 | PIK3CG | 0.39231870 |
| 125 | CDK18 | 0.39191600 |
| 126 | CAMK2B | 0.36845834 |
| 127 | CDC42BPA | 0.36719168 |
| 128 | ROCK1 | 0.36389092 |
| 129 | CSNK2A2 | 0.33376508 |
| 130 | CDK4 | 0.33257343 |
| 131 | ATR | 0.30289959 |
| 132 | PAK2 | 0.29623542 |
| 133 | MAPK11 | 0.29264194 |
| 134 | CSNK2A1 | 0.28667756 |
| 135 | MAP2K6 | 0.27606222 |
| 136 | FER | 0.27392417 |
| 137 | PRKAA1 | 0.27186611 |
| 138 | MAP3K6 | 0.26986129 |
| 139 | MTOR | 0.26634211 |
| 140 | PRKACG | 0.26257123 |
| 141 | MAP2K2 | 0.24650379 |
| 142 | PRKACB | 0.24377059 |
| 143 | PIM2 | 0.24272311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.10082833 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.02618972 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.00972113 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91635494 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82207402 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75870037 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51875342 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.29568136 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.28435649 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24210929 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.15425210 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13186230 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01298669 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.97843336 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90926415 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.88419989 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.88265327 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.86330069 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85742736 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85542333 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83088525 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75119597 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.70495929 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.69407914 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.69258908 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64671455 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56022555 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55370642 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54397141 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.50177754 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48503002 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42728674 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38549274 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37687772 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36463420 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34393080 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29610742 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28691044 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26630643 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.25053131 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24533320 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23593184 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.19846801 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19659342 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19101012 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18678688 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17460908 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17359257 |
| 49 | Proteasome_Homo sapiens_hsa03050 | 1.16800172 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15006386 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14935589 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14680485 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14190954 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11618917 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11106156 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10816546 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04848568 |
| 58 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04151590 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02742549 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 1.02223889 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97524218 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97312519 |
| 63 | Mismatch repair_Homo sapiens_hsa03430 | 0.95200877 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93567776 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.91191816 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90981277 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90086284 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89509806 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88701028 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.88436671 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87919464 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87520214 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86482765 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84275449 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84038617 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82148025 |
| 77 | RNA polymerase_Homo sapiens_hsa03020 | 0.80541590 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79176626 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72043630 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71604625 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70944368 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67667894 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67345971 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66929780 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.66132675 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65908843 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65189384 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64027876 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62470720 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62177087 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.61081188 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60158961 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58331048 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55677189 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.52722952 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50923356 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.49814546 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49401555 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49243304 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48241412 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47946595 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.46510778 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46449752 |
| 104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44470278 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44161584 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.43091691 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41708179 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40738764 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39229344 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.38391776 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37293166 |
| 112 | Homologous recombination_Homo sapiens_hsa03440 | 0.36551215 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36472335 |
| 114 | Base excision repair_Homo sapiens_hsa03410 | 0.35866824 |
| 115 | RNA transport_Homo sapiens_hsa03013 | 0.35479704 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35259610 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.34508998 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34436561 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33067281 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31154836 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30065111 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.28748443 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.27381447 |
| 124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.26630944 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.26150897 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25913706 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25732190 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20864668 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19741426 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18794146 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17546931 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17423002 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16517074 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15743847 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14378330 |

